ASTAIRE

A Double-Blind, Randomised, Placebo-Controlled, Multicentre, Dose-Escalating Study of AZD1305 Given Intravenously for Conversion to Sinus Rhythm in Patients with Atrial Fibrillation

Stadium
klaar
Middel
AZD1305
Populatie
Ritme
Fase
II
First Patient In
-
Last Patient In
-
Last Patient Last Visit
-
De pagina is verlopen.